Inflammation is already elevated at the earliest stage of cardiovascular-kidney-metabolic syndrome

A new analysis of U.S. national health data finds that high-sensitivity C-reactive protein (hs-CRP), a blood marker of inflammation, rises across the stages of cardiovascular-kidney-metabolic (CKM) syndrome, with the largest increase at the earliest stage. This suggests that inflammation is already elevated at the onset of the syndrome.